Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets

About 20–30% of premenopausal women have metabolic syndrome, and the number is almost double in postmenopausal women, and these women have an increased risk of hepatosteatosis. Postmenopausal women with metabolic syndrome are often treated with hormone replacement therapy (HRT), but estrogens in cur...

Descrición completa

Detalles Bibliográficos
Autores principales: Zuo, Qianying, Chen, Karen L., Arredondo Eve, Alicia, Liu, Yu-Jeh, Kim, Sung Hoon, Katzenellenbogen, Benita S., Katzenellenbogen, John A., Madak-Erdogan, Zeynep
Formato: Online Artigo Texto
Idioma:English
Publicado: MDPI 2021
Materias:
Article
Acceso en liña:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540756/
https://www.ncbi.nlm.nih.gov/pubmed/34684335
http://dx.doi.org/10.3390/nu13103334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540756/
https://www.ncbi.nlm.nih.gov/pubmed/34684335
http://dx.doi.org/10.3390/nu13103334

Títulos similares